{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T14:05:34Z","timestamp":1774274734222,"version":"3.50.1"},"reference-count":16,"publisher":"Japanese Pharmacological Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Folia Pharmacologica Japonica","Folia Pharmacol. Jpn."],"published-print":{"date-parts":[[2018]]},"DOI":"10.1254\/fpj.151.221","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T22:28:50Z","timestamp":1525991330000},"page":"221-227","source":"Crossref","is-referenced-by-count":1,"title":["Pharmacological action and clinical outcome of newly developed NSAIDs patch, \u201cLOQOA<sup>\u00ae <\/sup>tape\u201d","\u65b0\u898fNSAIDs\u30a8\u30b9\u30d5\u30eb\u30eb\u30d3\u30d7\u30ed\u30d5\u30a7\u30f3\u8cbc\u4ed8\u5264\uff08\u30ed\u30b3\u30a2<sup>\u00ae<\/sup>\u30c6\u30fc\u30d7\uff09\u306e\u85ac\u7406\u5b66\u7684\u7279\u9577\u3068\u81e8\u5e8a\u8a66\u9a13\u6210\u7e3e"],"prefix":"10.1254","volume":"151","author":[{"given":"Noboru","family":"Otsuka","sequence":"first","affiliation":[{"name":"Senior Specialist Office and Business Planning and Development Division for International Business, Taisho Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuko","family":"Yataba","sequence":"additional","affiliation":[{"name":"Regulatory Affairs, Taisho Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"3) Toda Y, et al. Pharmacology & Pharmacy. 2016;7:305-312.","DOI":"10.4236\/pp.2016.78037"},{"key":"2","doi-asserted-by":"crossref","unstructured":"5) Carabaza A, et al. J Clin Pharmacol. 1996;36:505-512.","DOI":"10.1002\/j.1552-4604.1996.tb05040.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"7) Sugimoto M, et al. Drug Dev Res. 2016;77:206-211.","DOI":"10.1002\/ddr.21314"},{"key":"4","doi-asserted-by":"crossref","unstructured":"8) Sugimoto M, et al. Drug Dev Res. 2016;77:20-28.","DOI":"10.1002\/ddr.21288"},{"key":"5","doi-asserted-by":"crossref","unstructured":"9) Kawabata A. Biol Pharm Bull. 2011;34:1170-1173.","DOI":"10.1248\/bpb.34.1170"},{"key":"6","doi-asserted-by":"crossref","unstructured":"10) Yataba I, et al. Eur J Clin Pharmacol. 2016;72:53-59.","DOI":"10.1007\/s00228-015-1960-6"},{"key":"7","doi-asserted-by":"crossref","unstructured":"11) Rannou F, et al. Semin Arthritis Rheum. 2016;45:S18-S21.","DOI":"10.1016\/j.semarthrit.2015.11.007"},{"key":"8","doi-asserted-by":"crossref","unstructured":"12) Yataba I, et al. J Pain Res. 2017;11:867-880.","DOI":"10.2147\/JPR.S131779"},{"key":"9","doi-asserted-by":"crossref","unstructured":"13) Yataba I, et al. Mod Rheumatol. 2016;27:130-136.","DOI":"10.1080\/14397595.2016.1176624"},{"key":"10","doi-asserted-by":"crossref","unstructured":"15) Yataba I, et al. Clin Drug Investig. 2016;36:673-682.","DOI":"10.1007\/s40261-016-0412-0"},{"key":"11","doi-asserted-by":"crossref","unstructured":"16) Otsuka N, et al. Clin Exp Nephrol. 2017;22:1060-1067.","DOI":"10.1007\/s10157-017-1406-9"},{"key":"12","doi-asserted-by":"crossref","unstructured":"17) Peniston JH, et al. Phys Sportsmed. 2011;39:31-38.","DOI":"10.3810\/psm.2011.09.1918"},{"key":"13","doi-asserted-by":"crossref","unstructured":"18) Shainhouse JZ, et al. Am J Ther. 2010;17:566-576.","DOI":"10.1097\/MJT.0b013e3181d169b5"},{"key":"14","unstructured":"19) European Medicines Agency. Guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis. 2010. p. 1-14. (Last accessed Jan 5, 2018)."},{"key":"15","doi-asserted-by":"crossref","unstructured":"22) Yoshimura N, et al. Int J Epidemiol. 2010;39:988-995.","DOI":"10.1093\/ije\/dyp276"},{"key":"16","doi-asserted-by":"crossref","unstructured":"23) Nakamura K. J Orthop Sci. 2008;13:1-2.","DOI":"10.1007\/s00776-007-1202-6"}],"container-title":["Folia Pharmacologica Japonica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fpj\/151\/5\/151_221\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T22:12:39Z","timestamp":1571350359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fpj\/151\/5\/151_221\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1254\/fpj.151.221","relation":{},"ISSN":["0015-5691","1347-8397"],"issn-type":[{"value":"0015-5691","type":"print"},{"value":"1347-8397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}